Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Update on Omalizumab for Urticaria: What's New in the Literature from Mechanisms to Clinic.
Larenas-Linnemann DES, Parisi CAS, Ritchie C, Cardona-Villa R, Cherrez-Ojeda I, Cherrez A, Ensina LF, Garcia E, Medina IV, Rodríguez-González M, Caraballo JMS. Larenas-Linnemann DES, et al. Among authors: ensina lf. Curr Allergy Asthma Rep. 2018 May 9;18(5):33. doi: 10.1007/s11882-018-0787-5. Curr Allergy Asthma Rep. 2018. PMID: 29744661 Review.
Fatal and Near-Fatal Anaphylaxis: Data From the European Anaphylaxis Registry and National Health Statistics.
Höfer V, Dölle-Bierke S, Francuzik W, Ruëff F, Sabouraud-Leclerc D, Treudler R, Moeser A, Hartmann K, Pföhler C, Wagner N, Ensina LF, Wedi B, Cardona V, Worm M. Höfer V, et al. Among authors: ensina lf. J Allergy Clin Immunol Pract. 2024 Jan;12(1):96-105.e8. doi: 10.1016/j.jaip.2023.09.044. Epub 2023 Oct 9. J Allergy Clin Immunol Pract. 2024. PMID: 37816460
The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update.
Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica GW, Church MK, Ensina LF, Giménez-Arnau A, Godse K, Gonçalo M, Grattan C, Hebert J, Hide M, Kaplan A, Kapp A, Abdul Latiff AH, Mathelier-Fusade P, Metz M, Nast A, Saini SS, Sánchez-Borges M, Schmid-Grendelmeier P, Simons FE, Staubach P, Sussman G, Toubi E, Vena GA, Wedi B, Zhu XJ, Maurer M; European Academy of Allergy and Clinical Immunology; Global Allergy and Asthma European Network; European Dermatology Forum; World Allergy Organization. Zuberbier T, et al. Among authors: ensina lf. Allergy. 2014 Jul;69(7):868-87. doi: 10.1111/all.12313. Epub 2014 Apr 30. Allergy. 2014. PMID: 24785199
Multinational experience with hypersensitivity drug reactions in Latin America.
Jares EJ, Sánchez-Borges M, Cardona-Villa R, Ensina LF, Arias-Cruz A, Gómez M, Barayazarra S, Bernstein JA, Serrano CD, Cuello MN, Morfin-Maciel BM, De Falco A, Cherrez-Ojeda I; Latin America Drug Allergy Interest Group. Jares EJ, et al. Among authors: ensina lf. Ann Allergy Asthma Immunol. 2014 Sep;113(3):282-9. doi: 10.1016/j.anai.2014.06.019. Epub 2014 Jul 24. Ann Allergy Asthma Immunol. 2014. PMID: 25065979
Omalizumab in Chronic Spontaneous Urticaria: A Brazilian Real-Life Experience.
Ensina LF, Valle SO, Juliani AP, Galeane M, Vieira dos Santos R, Arruda LK, Melo JM, de Souza PK, Serpa FS, de Andrade DM, França AT, Campos RA, Camelo-Nunes I, Solé D. Ensina LF, et al. Int Arch Allergy Immunol. 2016;169(2):121-4. doi: 10.1159/000444985. Epub 2016 Apr 8. Int Arch Allergy Immunol. 2016. PMID: 27055122
Omalizumab as Third-Line Therapy for Urticaria During Pregnancy.
Ensina LF, Cusato-Ensina AP, Camelo-Nunes IC, Solé D. Ensina LF, et al. J Investig Allergol Clin Immunol. 2017;27(5):326-327. doi: 10.18176/jiaci.0179. J Investig Allergol Clin Immunol. 2017. PMID: 29057743 Free article. No abstract available.
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria.
Zuberbier T, Aberer W, Asero R, Abdul Latiff AH, Baker D, Ballmer-Weber B, Bernstein JA, Bindslev-Jensen C, Brzoza Z, Buense Bedrikow R, Canonica GW, Church MK, Craig T, Danilycheva IV, Dressler C, Ensina LF, Giménez-Arnau A, Godse K, Gonçalo M, Grattan C, Hebert J, Hide M, Kaplan A, Kapp A, Katelaris CH, Kocatürk E, Kulthanan K, Larenas-Linnemann D, Leslie TA, Magerl M, Mathelier-Fusade P, Meshkova RY, Metz M, Nast A, Nettis E, Oude-Elberink H, Rosumeck S, Saini SS, Sánchez-Borges M, Schmid-Grendelmeier P, Staubach P, Sussman G, Toubi E, Vena GA, Vestergaard C, Wedi B, Werner RN, Zhao Z, Maurer M; Endorsed by the following societies: AAAAI, AAD, AAIITO, ACAAI, AEDV, APAAACI, ASBAI, ASCIA, BAD, BSACI, CDA, CMICA, CSACI, DDG, DDS, DGAKI, DSA, DST, EAACI, EIAS, EDF, EMBRN, ESCD, GA²LEN, IAACI, IADVL, JDA, NVvA, MSAI, ÖGDV, PSA, RAACI, SBD, SFD, SGAI, SGDV, SIAAIC, SIDeMaST, SPDV, TSD, UNBB, UNEV and WAO. Zuberbier T, et al. Among authors: ensina lf. Allergy. 2018 Jul;73(7):1393-1414. doi: 10.1111/all.13397. Allergy. 2018. PMID: 29336054
Learnings from real-life experience of using omalizumab for chronic urticaria in Latin America.
Cherrez-Ojeda I, Maurer M, Bernstein JA, Vanegas E, Felix M, Ramon GD, Ensina LF, Larco Sousa JI, Matos Benavides EE, Cardona Villa R, Latour Staffeld P, Morfin-Maciel BM, Mori J, Wilches C P, Mata VL, Cherrez A. Cherrez-Ojeda I, et al. Among authors: ensina lf. World Allergy Organ J. 2019 Feb 23;12(2):100011. doi: 10.1016/j.waojou.2019.100011. eCollection 2019. World Allergy Organ J. 2019. PMID: 30937137 Free PMC article.
97 results